BRCA2 and cancer: Hence, our work reveals a previously unknown function of MDC1 in RF biology, a role that contributes to DNA damage induced by genotoxic agents and the response of BRCA1- or BRCA2-deficient tumors to clinically relevant anti-cancer drugs, such as PARPi and cisplatin.